Products for Research Use Only
RegisterLogin

CBR-470-1

CAT: 0804-HY-134205A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-134205A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1) . CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP+-induced cytotoxicity through activation of the Keap1-Nrf2 cascade[1][2].
CAS Number
2416095-06-0
UNSPSC
12352005
Target
Keap1-Nrf2
Type
Reference compound
Related Pathways
NF-κB
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cbr-470-1.html
Purity
98.02
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
CC(C)CN[C@H]([C@@H](S(=O)(C1=CC=C(Cl)C=C1)=O)C2)CS2(=O)=O
Molecular Formula
C14H20ClNO4S2
Molecular Weight
365.89
References & Citations
[1]Bollong MJ, et, al. A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature. 2018 Oct;562 (7728) :600-604.|[2]Zheng J, et, al. PGK1 inhibitor CBR-470-1 protects neuronal cells from MPP+. Aging (Albany NY) . 2020 Jul 10;12 (13) :13388-13399.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-134001-01CBR-470-2
HY-151105CBR Agonist-1
HY-146009AL-470
HY-101932-01TNP-470
HY-145986CBR-6672
HY-100012-01CBR-5884
HY-145985CBR-3465
HY-W999604CRBN ligand-470
HY-151107CBR Agonist-2
HY-117485CBR-096-4

Alternative Products

CatalogName
BA8613-100CBR-470-1
BC167790-01CBR 470-1
RWD09500-01CBR-470-2

Popular Products